Table 4. Biomarkers and Mortality Risk.
Number of Events/number at risk (%) | Unadjusted Hazards Ratio (95% CI) | p | Multivariable-adjusted Hazards Ratio (95%CI)* | p | |
---|---|---|---|---|---|
ADMA | |||||
ADMA (per SD increase) | 1.10 (0.99-1.22) | 0.09 | 1.21 (1.07-1.37) | 0.003 | |
Quartile 1 | 50/832 (6.0) | Referent | - | Referent | - |
Quartile 2 | 61/827 (7.4) | 1.23 (0.85-1.79) | 0.27 | 1. 08 (0.71-1.64) | 0.71 |
Quartile 3 | 79/834 (9.5) | 1.38 (0.97-1.97) | 0.07 | 1.15 (0.77-1.71) | 0.51 |
Quartile 4 | 95/827 (11.5) | 1.33 (0.95-1.88) | 0.10 | 1.53 (1.05-2.23) | 0.03 |
Trend | 1.09 (0.98-1.21) | 0.08 | 1.15 (1.02-1.30) | 0.02 | |
L-arginine | |||||
L-Arg (per SD increase) | 0.87 (0.77-0.98) | 0.02 | 0.89 (0.77-1.02) | 0.08 | |
Quartile 1 | 71/821 (8.7) | Referent | - | Referent | - |
Quartile 2 | 64/833 (7.7) | 1.03 (0.73-1.44) | 0.88 | 0.96 (0.66-1.41) | 0.85 |
Quartile 3 | 88/850 (10.4) | 0.98 (0.71-1.34) | 0.88 | 0.86 (0.60-1.24) | 0.43 |
Quartile 4 | 62/816 (7.6) | 0.70 (0.50-0.98) | 0.04 | 0.73 (0.50-1.07) | 0.10 |
Trend | 0.90 (0.81-0.997) | 0.04 | 0.90 (0.80-1.02) | 0.09 | |
Arg/ADMA | |||||
Arg/ADMA (per SD increase) | 0.82 (0.72-0.94) | 0.003 | 0.80 (0.69-0.93) | 0.004 | |
Quartile 1 | 92/824 (11.2) | Referent | - | Referent | - |
Quartile 2 | 77/827 (9.3) | 0.85 (0.63-1.15) | 0.30 | 0.76 (0.53-1.07) | 0.12 |
Quartile 3 | 70/835 (8.4) | 0.85 (0.62-1.16) | 0.30 | 0.69 (0.48-1.01) | 0.05 |
Quartile 4 | 46/834 (5.5) | 0.52 (0.36-0.74) | 0.0003 | 0.49 (0.33-0.74) | 0.0007 |
Trend | 0.83 (0.75-0.93) | 0.0006 | 0.80 (0.71-0.91) | 0.0007 |
adjusted for age, sex, systolic and diastolic BP, hypertension treatment, smoking, diabetes, total/HDL cholesterol, creatinine, prevalent CVD, and logBNP, log renin, log Hcy, log UACR, and log CRP. N=2,750 for the multivariable adjusted model. Mean (SD) was 0.55 (0.13) μmol/l for ADMA, 78.9 (20.7) μmol/l for L-arginine, and 149.4 (44.4) for the Arg/ADMA ratio.